Elevance Health Inc.
Elevance Health Reports Q1 2024 Results and Raises Full-Year Guidance
Summary
Elevance Health, Inc. reported Q1 2024 operating revenue of $42.3 billion, up 0.9% year-over-year, with diluted EPS of $9.59, up 15.5%. The company raised its full-year diluted EPS guidance to greater than $34.05 and adjusted diluted EPS to greater than $37.20. Elevance Health also announced a strategic partnership with Clayton, Dubilier & Rice to advance primary care and physician enablement.
Profitelligence Alerts
Get alerts for ELV
Be first to know when Elevance Health Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Official SEC Documents
Advertisement